Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
about
P1343
T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residuesT cells reactive to an inducible heat shock protein induce disease in toxin-induced interstitial nephritisType 2 cytokines predominate in the human CD4(+) T-lymphocyte response to Epstein-Barr virus nuclear antigen 1.Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationThe virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosisMolecular analysis of the helper T cell response in murine interstitial nephritis. T cells recognizing an immunodominant epitope use multiple T cell receptor V beta genes with similarities across CDR3.Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor.Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritisActivation of interleukin 2 and interleukin 2 receptor (Tac) promoter expression by the trans-activator (tat) gene product of human T-cell leukemia virus, type I.Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells.Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritisNatural killer cells are present in the normal human lung but are functionally impotent.In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani.Human T-cell clones to the 70-kilodalton heat shock protein of Mycobacterium leprae define mycobacterium-specific epitopes rather than shared epitopes.Schistosoma japonicum egg antigen-specific T cell lines in man. Induction of helper and suppressor T cell lines and clones in vitro in a patient with chronic schistosomiasis japonicaDemonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation.Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation.Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trialHuman T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cellsTransformation of owl monkey T cells in vitro with Herpesvirus saimiri.Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidinePossible involvement of the T4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of CTL-target cell bindingLymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsTLiSA1, a human T lineage-specific activation antigen involved in the differentiation of cytotoxic T lymphocytes and anomalous killer cells from their precursorsT cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells.Immune regulation of in vitro murine megakaryocyte development. Role of T lymphocytes and Ia antigen expression.Retroviral activation of interleukin 2 gene in a gibbon ape T cell lymphoma line.High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations.Isolation of a human genomic fragment, co-amplified with c-Ki-ras, that affects plasmid supercoiling in E. coli.Abundant transcription of a cellular gene in T cells infected with human T-cell leukemia-lymphoma virus.Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif.Ectopic lymphokine gene expression in human peripheral blood lymphocytes in vivo.Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 virusesHerpesvirus saimiri-induced lymphoblastoid rabbit cell line: growth characteristics, virus persistence, and oncogenic properties
P2860
Q24679910-B13222C5-8E1D-4254-B89E-5B5DA40539CDQ28383125-652D65C7-DC94-4656-92E7-221574220037Q30305830-434E4143-6D4E-4501-9B8C-23D1B91B779AQ30452157-732220AF-FBCF-4772-86B5-EB8660111EF3Q33396983-0361D5A4-20FA-4B39-A839-8DE0F89A704DQ33808966-71081749-155F-488B-B50B-1E8043CE73BCQ34109682-25706E6A-3C33-4730-B817-4C69C47D202FQ34147153-F4934725-A5D0-44BF-9C80-76BD6802A6A9Q34158991-02CB4514-70DE-4F1F-89E9-0FA2B4F132BFQ34159098-225D7B23-864E-49DF-8E35-25F0B8D9FD91Q34191676-EFA40512-C96E-4164-9184-CA5350BE4BD9Q34334781-6C51AEC1-E140-4AF5-90EA-138573E14211Q34548750-F04B9929-F150-479E-8EA5-E6E2C552D962Q34563743-C689A582-6779-47B6-8D4B-2906420E2501Q34614312-B4C305CB-3E08-4C40-976B-7BDF84FF0B32Q34624661-F3FD8F90-8BA6-44C5-B1EA-D60280AF225DQ35106984-B5C6DCDA-6159-4F8E-BC15-A7D6FCC2845EQ35544385-1C3F8943-6B23-46FC-A3FB-756ED63039C5Q35586269-768F8523-B14C-438B-9002-0D0400A7CF53Q35609365-F829F5C1-266D-459E-94E0-2B37C00C2039Q35611807-86A88931-0FD3-461E-A8D6-39DD2BE8FE5BQ35994341-7BBB1B1D-1291-497E-BC61-48EC782DACAFQ36258122-79148C9A-8BBF-460C-8E2E-C0530BE6FED4Q36273704-3F6F6264-29F9-4325-AA1A-8C17DAFFE00EQ36324599-430664E2-5CAA-40C1-B139-DDEC8F229C6BQ36348608-3549010A-C441-4330-9EE6-8750156A61A4Q36349100-6D6D0AEC-F1D6-44E5-89BF-BB391613A792Q36349935-BD55D782-780A-4FFD-B5CC-D1156164EDF9Q36351370-07491EBD-4440-4908-B870-E54DAF6E38B1Q36351418-DEA402F9-B0D1-4446-BD0F-E3CC7A054500Q36353125-8E74FF00-E137-4677-8485-0E9DACAAE4EEQ36361251-9612AEFC-0403-401A-A757-FD73E1A751EDQ36401710-239B9944-6D99-46AA-B437-053B925E5106Q36426805-1A830AA3-D097-48FF-9F89-FF39B04968C7Q36597065-C690C743-7CD4-4BD7-A6DB-FEC0C562759CQ36645694-2266513A-CF7D-4632-81C8-B61643C85E32Q36733047-16E671B7-3287-4570-A4E4-657CD3C79C1EQ36816122-14FB4A1F-0B68-4188-A3AC-379DF2BEE872Q36898412-C2724BAE-8970-4929-A0A1-B308CF477253Q36904336-8885540A-800B-4425-94FC-FC711B09BA9F
P2860
Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Spontaneous release of a facto ...... line of primate tumor T cells.
@en
Spontaneous release of a facto ...... line of primate tumor T cells.
@nl
type
label
Spontaneous release of a facto ...... line of primate tumor T cells.
@en
Spontaneous release of a facto ...... line of primate tumor T cells.
@nl
prefLabel
Spontaneous release of a facto ...... line of primate tumor T cells.
@en
Spontaneous release of a facto ...... line of primate tumor T cells.
@nl
P2093
P1476
Spontaneous release of a facto ...... line of primate tumor T cells
@en
P2093
Hopkins RF 3rd
Kawakami TG
Neubauer RH
Ruscetti FW
P304
P407
P4510
P577
1981-11-01T00:00:00Z